Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Mobile Sensor Technologies to Assess General Symptomology of Cancer Patients

NCT04465214 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04465214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04465214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Mobile Sensor Technologies to Assess General Symptomology of Cancer Patients
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
November 23, 2020
Completion date
April 10, 2024
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, lung cancer, neoplasms, prostate cancer, solid tumors